Genetic susceptibility to Graves ophthalmopathy: The role of polymorphisms in proinflammatory cytokine genes

Eye

Volumn 24, Issue 6, 2010, Pages 1058-1063

  Anvari, M ^a   Khalilzadeh, O ^a   Esteghamati, A ^b   Esfahani, S A ^a   Rashidi, A ^b   Etemadi, A ^a   Mahmoudi, M ^a,c   Amirzargar, A A ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gene; Grave?s disease; Interleukin; Ophthalmopathy; Polymorphism

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ALLELE; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ENDOCRINE OPHTHALMOPATHY; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77953582693     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2009.244     Document Type: Article

References (44)

1. Weetman AP. Graves' disease. N Engl J Med 2000; 343: 1236-1248.
2. Weetman AP. Thyroid-associated ophthalmopathy. Autoimmunity 1992; 12: 215-222.
3. Gianoukakis AG, Smith TJ. Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy. Curr Opin Endocrinol Diabetes Obes 2008; 15: 446-452.
4. Heufelder AE. Pathogenesis of ophthalmopathy in autoimmune thyroid disease. Rev Endocr Metab Disord 2000; 1: 87-95.
5. Bahn RS, Heufelder AE. Role of connective tissue autoimmunity in Graves' ophthalmopathy. Autoimmunity 1992; 13: 75-79.
6. Kahaly G, Hansen C, Felke B, Dienes HP. Immunohistochemical staining of retrobulbar adipose tissue in Graves' ophthalmopathy. Clin Immunol Immunopathol 1994; 73: 53-62.
7. Heufelder AE, Bahn RS. Modulation of Graves' orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonists. Invest Ophthalmol Vis Sci 1994; 35: 120-127.
8. Korducki JM, Loftus SJ, Bahn RS. Stimulation of glycosaminoglycan production in cultured human retroocular fibroblasts. Invest Ophthalmol Vis Sci 1992; 33: 2037-2042.
9. Hiromatsu Y, Kaku H, Miyake I, Murayama S, Soejima E. Role of cytokines in the pathogenesis of thyroid-associated ophthalmopathy. Thyroid 2002; 12: 217-221.
10. Smith AJ, Humphries SE. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 2009; 20(1): 43-59.
11. Weetman AP. Thyroid-associated eye disease: pathophysiology. Lancet 1991; 338: 25-28.
12. Natt N, Bahn RS. Cytokines in the evolution of Graves' ophthalmopathy. Autoimmunity 1997; 26: 129-136.
13. Hiromatsu Y, Fukutani T, Ichimura M, Mukai T, Kaku H, Miyake I et al. Interleukin-12B gene polymorphism does not confer susceptibility to Graves' ophthalmopathy in Japanese population. Endocr J 2006; 53: 753-759.
14. Bednarczuk T, Hiromatsu Y, Seki N, Ploski R, Fukutani T, Kurylowicz A et al. Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy. Hum Immunol 2004; 65: 632-639.
15. Bougacha-Elleuch N, Rebai A, Mnif M, Makni H, Bellassouad M, Jouida J et al. Analysis of MHC genes in a Tunisian isolate with autoimmune thyroid diseases: implication of TNF-308 gene polymorphism. J Autoimmun 2004; 23: 75-80.
16. Bednarczuk T, Kurylowicz A, Hiromatsu Y, Kiljanskic J, Telichowska A, Nauman J. Association of G-174C polymorphism of the interleukin-6 gene promoter with Graves' ophthalmopathy. Autoimmunity 2004; 37: 223-226.
17. Chong KK, Chiang SW, Wong GW, Tam PO, Ng TK, Hu YJ et al. Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children. Invest Ophthalmol Vis Sci 2008; 49: 2409-2415.
18. Kamizono S, Hiromatsu Y, Seki N, Bednarczuk T, Matsumoto H, Kimura A et al. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese. Clin Endocrinol (Oxf) 2000; 52: 759-764.
19. Huber AK, Jacobson EM, Jazdzewski K, Concepcion ES, Tomer Y. Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/ T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab 2008; 93: 1077-1081.
20. Bednarczuk T, Gopinath B, Ploski R, Wall JR. Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack? Clin Endocrinol (Oxf) 2007; 67: 3-19.
21. Werner SC. Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 1977; 44: 203-204.
22. Vaidya B, Imrie H, Perros P, Dickinson J, McCarthy MI, Kendall-Taylor P et al. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy. Lancet 1999; 354: 743-744.
23. Esteghamati A, Khalilzadeh O, Mobarra Z, Anvari M, Tahvildari M, Mojazi Amiri H et al. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients. Eur J Intern Med 2009; 20: 424-428.
24. Khalilzadeh O, Anvari M, Esteghamati A, Mahmoudi M, Tahvildari M, Rashidi A et al. Graves' ophthalmopathy and gene polymorphisms in interleukin-1a, interleukin-1, interleukin-1 receptor, and interleukin-1 receptor antagonist. Clin Exp Ophthalm 2009; 37(6): 614-619.
25. Heufelder AE, Bahn RS. Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts. Eur J Clin Invest 1992; 22: 529-537.
26. Heufelder AE, Wenzel BE, Gorman CA, Bahn RS. Detection, cellular localization, and modulation of heat shock proteins in cultured fibroblasts from patients with extrathyroidal manifestations of Graves' disease. J Clin Endocrinol Metab 1991; 73: 739-745.
27. Smith TJ, Bahn RS, Gorman CA, Cheavens M. Stimulation of glycosaminoglycan accumulation by interferon gamma in cultured human retroocular fibroblasts. J Clin Endocrinol Metab 1991; 72: 1169-1171.
28. Ban Y, Tozaki T, Taniyama M, Nakano Y, Yoneyama K, Ban Y et al. Association studies of the IL-23R gene in autoimmune thyroid disease in the Japanese population. Autoimmunity 2009; 42: 126-130.
29. Heufelder AE, Bahn RS, Smith TJ. Regulation by glucocorticoids of interferon gamma-induced HLA-DR antigen expression in cultured human orbital fibroblasts. Clin Endocrinol (Oxf) 1992; 37: 59-63.
30. Heufelder AE, Smith TJ, Gorman CA, Bahn RS. Increased induction of HLA-DR by interferon-gamma in cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial dermopathy. J Clin Endocrinol Metab 1991; 73: 307-313.
31. Shiau MY, Huang CN, Yang TP, Hwang YC, Tsai KJ, Chi CJ et al. Cytokine promoter polymorphisms in Taiwanese patients with Graves' disease. Clin Biochem 2007; 40: 213-217.
32. Simmonds MJ, Heward JM, Howson JM, Foxall H, Nithiyananthan R, Franklyn JA et al. A systematic approach to the assessment of known TNF-alpha polymorphisms in Graves' disease. Genes Immun 2004; 5: 267-273.
33. Nakkuntod J, Wongsurawat T, Charoenwongse P, Snabboon T, Sridama V, Hirankarn N. Association of TNF-alpha, TNF-beta, IFN-gamma and IL-1Ra gene polymorphisms with Graves' disease in the Thai population. Asian Pac J Allergy Immunol 2006; 24: 207-211.
34. Weissensteiner T, Lanchbury JS. TNFB polymorphisms characterize three lineages of TNF region microsatellite haplotypes. Immunogenetics 1997; 47: 6-16.
35. Dinarello CA. Proinflammatory cytokines. Chest 2000; 118: 503-508.
36. Alayli G, Aydin F, Coban AY, Sullu Y, Canturk F, Bek Y et al. T helper 1 type cytokines polymorphisms: association with susceptibility to Behcet's disease. Clin Rheumatol 2007; 26: 1299-1305.
37. Carrozzo M, Uboldi de Capei M, Dametto E, Fasano ME, Arduino P, Broccoletti R et al. Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus. J Invest Dermatol 2004; 122: 87-94.
38. Ajjan RA, Watson PF, Weetman AP. Detection of IL-12, IL-13, and IL-15 messenger ribonucleic acid in the thyroid of patients with autoimmune thyroid disease. J Clin Endocrinol Metab 1997; 82: 666-669.
39. Wakelkamp IM, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF. TSH-R expression and cytokine profile in orbital tissue of active vs inactive Graves' ophthalmopathy patients. Clin Endocrinol (Oxf) 2003; 58: 280-287.
40. Hall MA, McGlinn E, Coakley G, Fisher SA, Boki K, Middleton D et al. Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun 2000; 1: 219-224.
41. Latsi P, Pantelidis P, Vassilakis D, Sato H, Welsh KI, du Bois RM. Analysis of IL-12 p40 subunit gene and IFN-gamma G5644A polymorphisms in Idiopathic Pulmonary Fibrosis. Respir Res 2003; 4: 6.
42. van Veen T, Crusius JB, Schrijver HM, Bouma G, Killestein J, van Winsen L et al. Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosis. Ann Neurol 2001; 50: 275.
43. Morahan G, Huang D, Ymer SI, Cancilla MR, Stephen K, Dabadghao P et al. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet 2001; 27: 218-221.
44. Pawlik A, Kurzawski M, Florczak M, Gawronska Szklarz B, Herczynska M. IL1beta+3953 exon 5 and IL-2 -330 promoter polymorphisms in patients with rheumatoid arthritis. Clin Exp Rheumatol 2005; 23: 159-164.